Molecular Mechanisms of Castrate-Resistant Prostate Cancer is a research paper published in Urologic Clinics of North America (2022). On theSindex it has a DataRank of 0. It has been cited 8 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph β no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full β never from an abstract alone.
Astellas Pharma US
National Cancer Institute
U.S. Department of Defense
AstraZeneca
Merck
National Institutes of Health
Pfizer
FWCI
0.68
Citation Percentile
0.7%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals